During the past decade, Alzheimer's Research and Treatment Center conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 14 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 13 clinical trials were completed. i.e. 76.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alzheimer's Research and Treatment Center" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Eisai Inc." with 3 trials sponsored, "Neurotrope Bioscience, Inc." with 3 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alzheimer's Research and Treatment Center" #1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Alzheimer's Research and Treatment Center" are "Alzheimer Disease" (13 trials), "Alzheimer's Disease" (11 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Early Alzheimer's Disease" (2 trials) and "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials). Many other conditions were trialed in "Alzheimer's Research and Treatment Center" in a lesser frequency.

Most popular intervention types in "Alzheimer's Research and Treatment Center" are "Drug" (33 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Gantenerumab" (5 trials), "Crenezumab" (3 trials), "AVP-786" (2 trials) and "Bryostatin 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alzheimer's Research and Treatment Center" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Alzheimer's Research and Treatment Center". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Alzheimer's Research and Treatment Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Alzheimer's Research and Treatment Center, 3 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".